Fundz

Bio Synchronicity reported raising $25,000 in an initial SEC Form D filing, from an offering of $200,000

PRIVATEJun 28, 2023$25K of $200K raised

Amount Raised

$25,000

$25,000 sold, per SEC Form D (first sale Jun 23, 2023)

Round Type

Pre-Seed

SpokaneBiotechnology

Quick answer

BioSynchronicity raised $25,000 in a Pre-Seed round, dated June 23, 2023. BioSynchronicity is based in Spokane, Washington, United States.

How much did BioSynchronicity raise?
BioSynchronicity raised $25,000 in a Pre-Seed round on June 23, 2023.
What does BioSynchronicity do?
BioSynchronicity Corporation is a USA based company founded and launched in June 2020 in the State of Washington.
Where is BioSynchronicity based and how big is it?
BioSynchronicity is based in Spokane, Washington, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as BioSynchronicity that raised within 45 days of this round, from Fundz verified event records.

  • Poseida Therapeutics, Inc. raised $25M on August 7, 2023.
  • Poseida Therapeutics, Inc. raised an undisclosed amount (Corporate Round) on August 7, 2023.
  • Gracell raised $150M (Post-IPO Equity) on August 7, 2023.
  • Neuralink raised $280M on August 4, 2023.
  • Persist AI raised $4M (Seed) on August 4, 2023.
  • Oragenics raised $850K (Series C) on August 4, 2023.

Who to call at BioSynchronicity, and when

A new round usually means BioSynchronicity is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BioSynchronicity raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioSynchronicity, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioSynchronicity. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioSynchronicity

Location

REGISTERED AGENTS INC.

Spokane, Washington, United States

About

BioSynchronicity Corporation is a USA based company founded and launched in June 2020 in the State of Washington. The global headquarters office was subsequently opened in Rochester, New York, in January, 2021. BioSynchronicity was tasked with designing and developing a reliable, simple, affordable, widely-available, and ultra-rapid SARS-CoV-2 antigen diagnostic test for hospital and point of care (POC) use, school and business screening programs, as well as self-administered testing at home through over-the-counter (OTC) sales where authorized by regulatory bodies. To meet this challenge, a global team of like-minded scientists, doctors, engineers, and other seasoned international business professionals was assembled, resulting in the creation of the innovative and accurate C-Sync™ COVID-19 Antigen Test, the C-SyncPlus™ COVID-19 Antigen Test, and the soon to be available C-Sync™ All-in-One COVID-19 Influenza A/B Combo Test.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioSynchronicity raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for BioSynchronicity's next move

See what Strategic adds

BioSynchronicity raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.